EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Rectus Femoris Muscle and Phase Angle as Prognostic Factor for 12-Month Mortality in a Longitudinal Cohort of Patients with Cancer (AnyVida Trial)

Cristina García-García iD, Isabel María Vegas-Aguilar, Rosalía Rioja-Vázquez, Isabel Cornejo-Pareja iD, Francisco J Tinahones, José Manuel García-Almeida iD

Nutrients · 2023

DOI: 10.3390/nu15030522 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrients, 2023. Verfasst von Cristina García-García und 5 weiteren Autor:innen. Beteiligte Einrichtung: Facultad de Medicina, Universidad of Málaga, 29010 Málaga, Spain. Hauptthemen laut MEDLINE: Malnutrition, Neoplasms. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto de Salud Carlos III, Andalusian Public Foundation for Biomedical Research in Malaga (FIMABIS), Ministerio de Ciencia e Innovación.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cancer-related malnutrition is still unrecognized and undertreated in clinical practice. The morphofunctional assessment of disease-related malnutrition (DRM) is a new approach that focuses on evaluating changes in body composition and function. The aim of this study is to evaluate the prognostic value of classic and emerging assessment of malnutrition at 12-months survival in cancer patients.

Methods

We conducted a prospective study on cancer outpatients. Bioelectrical impedance with phase angle (PhA), nutritional ultrasound by rectus femoris cross-sectional area (RFCSA), hand grip strength, and “Timed Up and Go Test” (TUG) were evaluated as predictors of mortality.

Results

Fifty-seven patients were included. The non-survivors had lower PhA values than the survivors (4.7° vs. 5.4°; p < 0.001), and we had the same results with RFCSA 2.98 cm2/m2 vs. 4.27 cm2/m2 (p = 0.03). Cut-off points were identified using the ROC (receiver operating characteristic) curves for PhA (≤5.6° cancer patients, ≤5.9° men, ≤5.3° women), RFCSA (≤4.47 cm2/m2 cancer patients, ≤4.47° men, ≤2.73° women) and rectus femoris-Y-axis (RF-Y-axis; ≤1.3 cm cancer patients, ≤1.06 men, ≤1 women). In multivariate logistic regression analysis, we found that high PhA was significantly associated with a lower mortality hazard ratio (HR: 0.42 95% CI: 0.21–0.84, p = 0.014). Likewise, high RFCSA was associated with a decrease in mortality risk in the crude model (HR: 0.61 95% CI: 0.39–0.96, p = 0.031). This trend was also maintained in the adjusted models by the confounding variables.

Conclusions

Low PhA and RFCSA values are significant independent predictors of mortality in cancer patients. These cut-off points are clinical data that can be used for nutritional assessment and the prediction of clinical outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MalnutritionNeoplasmsMaleHumansFemaleQuadriceps MuscleHand StrengthPrognosisProspective StudiesElectric ImpedanceNutritional Status

Stichwörter der Autor:innen

bioelectrical impedancecancerdisease-related malnutritionmortalityphase anglerectus femoris muscle

Autor:innen und Institutionen

  • Facultad de Medicina, Universidad of Málaga, 29010 Málaga, Spain.
  • Unidad de Gestión Clínica en Endocrinología y Nutrición, Hospital Universitario Virgen de la Victoria, 29010 Málaga, Spain.
  • Instituto de Investigación Biomédica de Málaga (IBIMA), Hospital Universitario Virgen de la Victoria, 29010 Málaga, Spain.
  • Asociación de Enfermeras de Nutrición y Dietética (ADENYD), 14004 Córdoba, Spain.
  • Centro de Investigacion Biomedica en Red de la Fisiopatología de la Obesidad y Nutricion (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 29010 Malaga, Spain.
  • Servicio de Endocrinología y Nutrición, Quirónsalud Hospital, 29010 Málaga, Spain.

ORCID-Profile: Cristina García-García, Isabel Cornejo-Pareja, José Manuel García-Almeida

Förderung

  • Instituto de Salud Carlos III
  • Andalusian Public Foundation for Biomedical Research in Malaga (FIMABIS)
  • Ministerio de Ciencia e Innovación
  • Fondo Europeo de Desarrollo Regional
  • “Centros de Investigación Biomédica en Red” (CIBERobn) of the Instituto de Salud Carlos III (ISCIII)
  • ISCIII
  • European Regional Development Fund (ERDF)

Zitieren

APA

García-García, C., Vegas-Aguilar, I. M., Rioja-Vázquez, R., Cornejo-Pareja, I., Tinahones, F. J., & García-Almeida, J. M. (2023). Rectus Femoris Muscle and Phase Angle as Prognostic Factor for 12-Month Mortality in a Longitudinal Cohort of Patients with Cancer (AnyVida Trial). Nutrients. https://doi.org/10.3390/nu15030522

Vancouver

García-García C, Vegas-Aguilar IM, Rioja-Vázquez R, Cornejo-Pareja I, Tinahones FJ, García-Almeida JM. Rectus Femoris Muscle and Phase Angle as Prognostic Factor for 12-Month Mortality in a Longitudinal Cohort of Patients with Cancer (AnyVida Trial). Nutrients. 2023. doi:10.3390/nu15030522

BibTeX
@article{GarcaGarca2023,
  author = {García-García, Cristina and Vegas-Aguilar, Isabel María and Rioja-Vázquez, Rosalía and Cornejo-Pareja, Isabel and Tinahones, Francisco J and García-Almeida, José Manuel},
  title = {Rectus Femoris Muscle and Phase Angle as Prognostic Factor for 12-Month Mortality in a Longitudinal Cohort of Patients with Cancer (AnyVida Trial)},
  journal = {Nutrients},
  year = {2023},
  doi = {10.3390/nu15030522}
}
Kostenlos starten →